The unique fibrosis model offered by InfiCure is attracting international attention. Last month the startup signed their first contract for a full-service preclinical pilot study to test two substances for an american client in Boston. The trial i currently underway, with all lab work beeing done on location in Umeå.
Clinical trials, intellectual property, and the entrepreneurship in medicine were just a few topics at the panel debate 24 of November. This year’s edition of the national roadshow Bubbel & Debatt took place at Umeå University where around 30 guests joined the panel in discussions on possibilities and hurdlers for innovation and collaboration in the life science field.
Umecrine Cognition announces positive top-line Phase 1 data with GR3027 in hepatic encephalopathy demonstrating safety, tolerability and CNS target engagement
Big pharma companies have tried and failed. But a small start-up in Umeå may have cracked the code. Betagenon has recently initiated a phase II clinical trial aiming to prove that obesity, diabetes and cardiovascular disease can all be treated by the same drug in humans.
The number of women in leading positions Umeå Biotech Incubator’s startup companies has tripled. Interesting and promising in itself, but also with the perspective that Vinnova are looking for more women innovation talents.
Successful projects with high potential for patient benefit gives Umeå Biotech Incubator renewed confidence from the Erling-Persson Family Foundation.
2017 Biotech Umeå Investment Day is arranged on February 2nd 2017 at Grand Hotel in Stockholm. Around 80 partnering meetings are expected to be held during the event.
Lipigon Pharmaceuticals and AstraZeneca’s agreement, reported earlier this spring, has potential to be one of the largest deals for any life sciences SME company in Sweden. We caught Lars Öhman, chairman of Lipigon, at BIO in San Francisco to learn more on how they did it and what to expect in the future.
Fredrik Almqvist, professor in organic chemistry at Umeå University and serial entrepreneur, receives Baltic’s collaboration and entrepreneurship award. He receives the award for successfully combining entrepreneurship with excellent research in chemical production and the combat against pathogenic bacteria.
Umecrine Cognition has raised new funds to support clinical development of novel drug candidate GR3027 for hepatic encephalopathy – Phase I clinical trial initiated.
LunaLEC from Umeå is ranked as one of the ten most promising clean tech startups in the Nordic countries.
Biotech Umeå Investment Day 2017
Biotech Umeå, Uminova Innovation
Box 7978, SE-907 19 Umeå